Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GGH | Q92820 | 1/20 | 0.31 |
| ▸ | PEPD | P12955 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28041941 | 0.98 | OR51E2 (0.40) | OR51E2MAPK1SLC13A3EGLN1TSHR | |
| SCHEMBL28144419 | 0.98 | OR51E2 (0.40) | OR51E2MAPK1SLC13A3EGLN1TSHR | |
| Ammonia Solution, Strong SCHEMBL28143479 | 0.98 | OR51E2 (0.40) | OR51E2MAPK1SLC13A3EGLN1TSHR | |
| SCHEMBL27977113 | 0.84 | GABBR2 (0.46) | OR51E2MAPK1SLC13A3EGLN1TSHR | |
| Methyl Alcohol SCHEMBL28524677 | 0.80 | MAPK1 (0.42) | OR51E2MAPK1SLC13A3EGLN1TSHR | |
| SCHEMBL16104630 | 0.79 | — | — | |
| SCHEMBL30271492 | 0.79 | OR51E2 (0.46) | OR51E2MAPK1SLC13A3EGLN1TSHR | |
| SCHEMBL63051 | 0.79 | — | — | |
| SCHEMBL11023524 | 0.78 | GABBR2 (0.44) | TSHRGABBR2CYP1A2THPOGABBR1 | |
| SCHEMBL9331454 | 0.78 | OR51E2 (0.40) | OR51E2MAPK1SLC13A3EGLN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146268-A1 | METHODS FOR IMPROVING YIELDS OF L-GLUFOSINATE | BASF SE (DE) | 2026-05-28 | — | — | US | claimed |
| EP-3423585-B1 | METHODS FOR MAKING L-GLUFOSINATE | BASF SE (DE) | 2026-04-08 | — | — | EP | claimed |
| US-12559777-B2 | Methods for improving yields of L-glufosinate | BASF SE (DE) | 2026-02-24 | — | — | US | claimed |
| US-12509709-B2 | Methods for making L-glufosinate | BASF SE (DE) | 2025-12-30 | — | — | US | claimed |
| US-20250327103-A1 | METHODS FOR MAKING L-GLUFOSINATE | BASF SE (DE) | 2025-10-23 | — | — | US | claimed |
| EP-4636081-A2 | METHODS FOR MAKING L-GLUFOSINATE | BASF SE (DE) | 2025-10-22 | — | — | EP | claimed |
| US-20250250596-A1 | METHODS FOR MAKING L-GLUFOSINATE | BASF SE (DE) | 2025-08-07 | — | — | US | claimed |
| US-12305207-B2 | Methods for making L-glufosinate | BASF SE (DE) | 2025-05-20 | — | — | US | claimed |
| CN-115058464-B | Method for preparing glufosinate-ammonium from 4- (methyl hydroxy phosphoryl) -2-carbonyl butyric acid | 湖北泰盛化工有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-20250084111-A1 | METHOD FOR PREPARING 4-(HYDROXYMETHYLPHOSPHINYL)-2-OXOBUTANOIC ACID | ZHEJIANG WYNCA CHEMICAL INDUSTRY GROUP CO., LTD (CN) | 2025-03-13 | — | — | US | claimed |
| US-5153355-A | Water soluble polymer phases or polymer and salt | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-06 | — | — | US | claimed |
| US-5130246-A | Culturing Escherichia to form transaminase | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-14 | — | — | US | claimed |
| EP-0472143-A1 | Process for the extractive separation of 1-phosphinothricin and l-glutamic acid in aqueous solution | Hoechst Schering AgrEvo GmbH (DE) | 1992-02-26 | — | — | EP | claimed |
| EP-0373597-A2 | Gene and gene structure coding for an aminotransferase, and microorganisms expressing this gene | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-06-20 | — | — | EP | claimed |
| EP-0367145-A2 | New process for the production of L-2-amino-4(hydroxymethyl-phospinyl)-butyric acid | MEIJI SEIKA KAISHA LTD. (JP) | 1990-05-09 | — | — | EP | claimed |
| EP-0349965-A2 | Novel genes encoding transaminase | MEIJI SEIKA KAISHA LTD. (JP) | 1990-01-10 | — | — | EP | claimed |
| EP-0249188-A2 | Process for the production of L-2-amino-4-(hydroxymethyl-phosphinyl)-butyric acid | MEIJI SEIKA KAISHA LTD. (JP) | 1987-12-16 | — | — | EP | claimed |
| EP-0248357-A2 | Process for the preparation of L-phosphinothricine by transamination | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-12-09 | — | — | EP | claimed |
| EP-0030424-B1 | DERIVATIVES OF 4-(METHYLPHOSPHINYL)-2-OXOBUTANOIC ACID, HERBICIDAL COMPOSITIONS CONTAINING THEM, AND INTERMEDIATES AND METHODS FOR THEIR PRODUCTION | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-02-20 | — | — | EP | claimed |
| EP-0030424-A2 | Derivatives of 4-(methylphosphinyl)-2-oxobutanoic acid, herbicidal compositions containing them, and intermediates and methods for their production | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-06-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559777-B2 | Methods for improving yields of L-glufosinate | DAO, DDO, ABAT | OR51E2 2602/4885MAPK1 4138/4885SLC13A3 1266/4885 |
| US-20260146268-A1 | METHODS FOR IMPROVING YIELDS OF L-GLUFOSINATE | DAO, DDO, PNPO | OR51E2 3320/4885MAPK1 4105/4885SLC13A3 1719/4885 |
| US-20250327103-A1 | METHODS FOR MAKING L-GLUFOSINATE | DAO, DDO, GLUL | OR51E2 2891/4885MAPK1 4054/4885SLC13A3 1865/4885 |
| US-20250084111-A1 | METHOD FOR PREPARING 4-(HYDROXYMETHYLPHOSPHINYL)-2-OXOBUTANOIC ACID | CA2, CA7, CA6 | OR51E2 1818/4885MAPK1 1168/4885SLC13A3 251/4885 |
| US-12509709-B2 | Methods for making L-glufosinate | DAO, DDO, ABAT | OR51E2 3104/4885MAPK1 4543/4885SLC13A3 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.